Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation [Phase 2, Phase 3]

View source ↗

Summary

The Dominantly Inherited Alzheimer Network Trial, studying potential disease-modifying treatments for individuals at risk for or with familial early-onset Alzhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Familial
• Dementia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-02-04